|
SUPT7L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.780760E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.914300E-02 |
| Normal-vs-Stage2 |
1.722100E-02 |
| Normal-vs-Stage3 |
1.413600E-04 |
| Normal-vs-Stage4 |
3.408800E-04 |
| Stage1-vs-Stage2 |
1.396620E-01 |
| Stage1-vs-Stage3 |
7.478900E-03 |
| Stage1-vs-Stage4 |
2.814000E-02 |
| Stage2-vs-Stage3 |
6.828400E-01 |
| Stage2-vs-Stage4 |
6.410400E-01 |
| Stage3-vs-Stage4 |
9.009200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.298200E-03 |
| Normal-vs-AfricanAmerican |
3.048200E-01 |
| Normal-vs-Asian |
9.662600E-01 |
| Caucasian-vs-AfricanAmerican |
4.323600E-01 |
| Caucasian-vs-Asian |
2.412100E-02 |
| AfricanAmerican-vs-Asian |
4.254400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.699500E-02 |
| Normal-vs-Female |
1.004820E-03 |
| Male-vs-Female |
3.062200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.077650E-01 |
| Normal-vs-Age(41-60Yrs) |
1.903610E-03 |
| Normal-vs-Age(61-80Yrs) |
4.042300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.010200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.236300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.506220E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.413000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.300600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.220000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.213800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.70916999999715E-05 |
| Classical-VS-Follicular |
6.483800E-02 |
| Classical-VS-Other |
9.402400E-01 |
| Classical-VS-Normal |
1.230990E-01 |
| Tall-VS-Follicular |
6.447800E-02 |
| Tall-VS-Other |
4.239900E-02 |
| Tall-VS-Normal |
2.33959999995648E-06 |
| Follicular-VS-Other |
5.997200E-01 |
| Follicular-VS-Normal |
6.104900E-03 |
| Other-VS-Normal |
4.388600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.977360E-03 |
| Normal-vs-N1 |
1.061820E-01 |
| N0-vs-N1 |
5.615800E-01 |
|
|
